.Simply five months after safeguarding a $100 million IPO, Vast Bio is actually actually laying off ...
.The initial stages of oncology R&D aren't short of interesting brand new methods, and Halda Ther...
.Psychopharmacology has taken three short articles concerning midstage clinical test information ass...
.Avidity Biosciences impressed entrepreneurs along with phase 1/2 data in Duchenne muscular dystroph...
.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a stage 2 research study...
.Antibody-drug conjugates (ADCs) have been at the center of a lot of a billion-dollar biobuck licens...
.Property manager TPG, which has sustained biotechs including Sionna Therapies as well as Santa Ana ...
.Merck & Co.'s TIGIT system has actually experienced another obstacle. Months after shuttering a ...
.After a year specified by pipe hairstyles, the variation of its chief executive officer and also di...
.Cullinan Therapy was wowed good enough along with Port BioMed's bispecific immune activator that it...